Vimarsana
Biggest News Aggregation in the World

Sunfish Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunfish Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunfish Partners Today - Breaking & Trending Today

Funding frenzy to accommodate 'modern families': - Vimarsana News

Funding frenzy to accommodate 'modern families':

Fertility tech startups across the US have amassed more than $850 million in investments from tech-forward companies eager to build up access to pricey treatments such as IVF and egg freezing.

Solvemed raises £3.2m for ocular identification of neurological diseases - Vimarsana News

Solvemed raises £3.2m for ocular identification of neurological diseases

Examines people’s eyes for signs of neurodegenerative diseases including Parkinson’s, Alzheimer’s and multiple sclerosis

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round – TechCrunch - Vimarsana News

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round – TechCrunch

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. theoretical treatments but can’t actually make the molecules. The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it. After all, these ...

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round - Vimarsana News

Molecule.one grows its drug synthesis AI platform with a $4.6M seed round

Polish computational chemistry outfit Molecule.one has raised $4.6M to expand its quest to bring theoretical drug molecules to reality. Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. Molecule.one went on stage at Disrupt SF 2019's Startup Battlefield, where they explained the difficulty faced by the drug discovery industry, basically that they come up with lots of theoretical treatments but can't actually make the molecules.

Source: yahoo.com